Genetically modified crops engineered to produce drugs are to be grown commercially for the first time.
An American biotech company plans to start growing medicines to treat diarrhoea in modified rice in April. Its proposals were examined last week by regulatory bodies in California, but they have no power to stop the planting.
The rice will usher in a second generation of GM crops, which are bound to polarise opinion even more than those that have already caused controversy. Unlike current crops they could offer real benefits to millions of people – but they also pose far greater health risks.
Source: http://www.nzherald.co.nz/storydisplay.cfm?storyID=3546772%26thesection=news%26thesubsection=world
[Editor: The preceding article was not written by A4M/WHN]
